<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Monitoring inflammation in stroke using combined high resolution magnetic resonance imaging and synchrotron radiation-phase computed tomography (SR-PCT) of the mouse brain</title>
				<funder ref="#_pyKZjYW">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder ref="#_8W7NggF">
					<orgName type="full">Agence Nationale de la Recherche</orgName>
					<orgName type="abbreviated">ANR</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2015-06-15">June 15, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Vincent</forename><surname>Fernandez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CREATIS Françoise PEYRIN</orgName>
								<orgName type="institution" key="instit1">Elodie ONG *</orgName>
								<orgName type="institution" key="instit2">CREATIS Lise-Prune BERNER *</orgName>
								<orgName type="institution" key="instit3">ESRF and CREATIS Cécile OLIVIER</orgName>
								<orgName type="institution" key="instit4">ESRF and CREATIS Max LANGER</orgName>
								<orgName type="institution" key="instit5">ESRF and CREATIS Loriane WEBER</orgName>
								<orgName type="institution" key="instit6">ESRF and CREATIS David ROUSSEAU</orgName>
								<orgName type="institution" key="instit7">CREATIS Carole FRINDEL</orgName>
								<orgName type="institution" key="instit8">CREATIS Fabien CHAUVEAU</orgName>
								<address>
									<country>CRNL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lukas</forename><surname>Helfen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CREATIS Françoise PEYRIN</orgName>
								<orgName type="institution" key="instit1">Elodie ONG *</orgName>
								<orgName type="institution" key="instit2">CREATIS Lise-Prune BERNER *</orgName>
								<orgName type="institution" key="instit3">ESRF and CREATIS Cécile OLIVIER</orgName>
								<orgName type="institution" key="instit4">ESRF and CREATIS Max LANGER</orgName>
								<orgName type="institution" key="instit5">ESRF and CREATIS Loriane WEBER</orgName>
								<orgName type="institution" key="instit6">ESRF and CREATIS David ROUSSEAU</orgName>
								<orgName type="institution" key="instit7">CREATIS Carole FRINDEL</orgName>
								<orgName type="institution" key="instit8">CREATIS Fabien CHAUVEAU</orgName>
								<address>
									<country>CRNL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marlene</forename><surname>Wiart</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CREATIS Françoise PEYRIN</orgName>
								<orgName type="institution" key="instit1">Elodie ONG *</orgName>
								<orgName type="institution" key="instit2">CREATIS Lise-Prune BERNER *</orgName>
								<orgName type="institution" key="instit3">ESRF and CREATIS Cécile OLIVIER</orgName>
								<orgName type="institution" key="instit4">ESRF and CREATIS Max LANGER</orgName>
								<orgName type="institution" key="instit5">ESRF and CREATIS Loriane WEBER</orgName>
								<orgName type="institution" key="instit6">ESRF and CREATIS David ROUSSEAU</orgName>
								<orgName type="institution" key="instit7">CREATIS Carole FRINDEL</orgName>
								<orgName type="institution" key="instit8">CREATIS Fabien CHAUVEAU</orgName>
								<address>
									<country>CRNL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>CREATIS</roleName><forename type="first">Hugo</forename><surname>Rositi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">CREATIS Françoise PEYRIN</orgName>
								<orgName type="institution" key="instit1">Elodie ONG *</orgName>
								<orgName type="institution" key="instit2">CREATIS Lise-Prune BERNER *</orgName>
								<orgName type="institution" key="instit3">ESRF and CREATIS Cécile OLIVIER</orgName>
								<orgName type="institution" key="instit4">ESRF and CREATIS Max LANGER</orgName>
								<orgName type="institution" key="instit5">ESRF and CREATIS Loriane WEBER</orgName>
								<orgName type="institution" key="instit6">ESRF and CREATIS David ROUSSEAU</orgName>
								<orgName type="institution" key="instit7">CREATIS Carole FRINDEL</orgName>
								<orgName type="institution" key="instit8">CREATIS Fabien CHAUVEAU</orgName>
								<address>
									<country>CRNL</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Monitoring inflammation in stroke using combined high resolution magnetic resonance imaging and synchrotron radiation-phase computed tomography (SR-PCT) of the mouse brain</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-06-15">June 15, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">0924497BCC58A38D83AFEFB54B70EEB0</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T17:11+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study#3-K-edge imaging of Gadolinium</head><p>Further acquisitions using synchrotron radiations are in needed for publication of this work.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Stroke is one of the most common causes of death in the western world. Several lines of evidence suggest that inflammatory processes contribute to the destruction of neural tissue. To better understand and exploit the endogenous mechanisms at work in focal ischemia, molecular events need to be examined in detail in animal models of stroke. We recently demonstrated at ID19 that Synchrotron Radiation X-ray Phase Computed Tomography (SR-PCT) was an unvaluable complement to ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI in mouse models of ischemic stroke <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b1">2)</ref>. To overcome some limitations of USPIOs, new kinds of nanoparticles have been developed by our collaborators from the Laboratoire de Chimie de l'ENS Lyon (Stéphane Parola). These multimodal nanoparticles consist in a gadolinium (Gd)-based inorganic core (GdF 3 ) functionalized with a fluorochrome. Another limitation of the approach is the fact that neither MRI nor SR-PCT permits discriminating between nanoparticles and hemorrhagic transformation, a common complication of stroke (Figure <ref type="figure">1</ref>). Therefore, our current aim is to specifically image gadolinium. To this purpose, we plan to investigate two strategies: K-edge imaging using spectral CT (3) (with the arrival of the first commercial spectral scanner in Lyon in 2015) and K-edge imaging using synchrotron radiation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 1-Confounding effects of hemorrhagic transformation in a mouse model of stroke on µMRI and Synchrotron radiation phase-contrast µCT (SR-PCT).</head><p>The nanoparticles (NP) that were injected to the animal in order to detect macrophages (M ) (C) appear as a hypointense signal on µMRI (A) and hyperintense signal on SR-PCT (B). The hemorrhage (D) has the same hypointense (A) / hyperintense (B) signal and thus cannot be distinguish from NPs without slicing the brain.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p>K-edge describes a sudden increase in the attenuation coefficient of photons occurring at a photon energy just above the binding energy of the K shell electron of the atoms interacting with the photons. For this interaction to occur, the photons must have more energy than the binding energy of the K shell electrons. A photon having an energy just above the binding energy of the electron is therefore more likely to be absorbed than a photon having an energy just below this binding energy. To perform K-edge imaging of a given element, two absorption images are respectively acquired just below/above the binding energy of the K shell electrons (4). The subtraction of these two acquisitions produces a specific image of the element. For proof-of-concept of k-edge imaging, we have first prepared tubes with a range of concentration for USPIO and GdF3. We have then used mouse brains (N=3) that had been stereotaxically injected with GdF3.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>During a pilot study, we have shown that K-edge imaging of gadolinium was feasible at ID19 thanks to the set-up of a monochromator allowing to acquire images at 50 keV and 50.4 keV (K-edge of Gd = 50.2 keV) (Figure <ref type="figure" target="#fig_0">2</ref>). Moreover, while scanning a mouse brain sample stereotaxically injected with the Gd-based nanoparticles, we realized that bleeding had occurred on one side of the brain because K-edge imaging did not produce any signal on this side (Figure <ref type="figure">3</ref>). Therefore K-edge imaging with synchrotron radiation appears as a promising approach to distinguish nanoparticles from hemorrhage.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 3-Proof of concept of discrimination between Gadolinium and hemorrhage with K-edge imaging.</head><p>One mouse was stereotaxically injected with Gadolinium-based nanoparticles in the left and right hemisphere, resulting in hypointense signal on MRI (A) and hyperintense signal on SR-PCT (B). Kedge imaging showed a hyperintense signal in the right hemisphere. The injection in the left hemisphere had inadvertently provoked a hemorrhage. This was evidenced with K-edge imaging without having to slice the brain.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion &amp; perspectives</head><p>The next step is to evaluate the sensitivity of the technique and to test it in a mouse model of stroke (proposal to be submitted in September). In a first set of experiment, phantoms will be prepared with a range of hybrid nanoparticles concentrations to assess the sensitivity of detection. In a second set of experiment, the same range of concentrations will be stereotaxically injected into the brain of C57/Bl6 adult male mice (N=6) to perform the same tests ex vivo. In a last set of experiment, mice (N=6) will undergo middle cerebral artery occlusion followed by MRI at Day 0 (before injection) and Day 1 (24h after injection) according to our well-established protocol. After the last imaging exam, mouse heads (brain within the skull) will be collected and prepared for K-edge imaging. After K-edge imaging, brains will be extracted from the skull, sliced and observed under the microscope to detect hemorraghic events as well nanoparticles thanks to their fluorescence. These experiments will provide a reference frame for K-edge imaging with spectral CT, a new technology with high potential for in-vivo molecular imaging with CT.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 -</head><label>2</label><figDesc>Figure 2-Proof of concept of specific imaging of gadolinium with K-edge imaging. Phantoms were prepared with a range of concentrations of iron oxide nanoparticles (USPIO) on the one hand (N=2: 500 and 250 mM), and a range of concentrations of Gadolinium-based nanoparticles on the other hand (N=2: 500 and 250 mM) prepared in PBS (N=1 phantom with PBS only). Absorption images were acquired at 50 keV and at 50.4 keV (left image). Subtraction of the two acquisitions depicts the tubes with Gadolinium only (right image).</figDesc><graphic coords="3,33.95,621.85,337.80,166.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="4,33.95,91.55,345.15,172.55" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>This work was performed within the framework of the <rs type="projectName">LABEX PRIMES</rs> (<rs type="grantNumber">ANR-11-LABX-0063</rs>) of <rs type="institution">Université de Lyon</rs> and was supported by the <rs type="funder">European Synchrotron Research Facility (ESRF</rs>, project <rs type="grantNumber">LS-2292</rs>) by allocation of beam time.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funded-project" xml:id="_8W7NggF">
					<idno type="grant-number">ANR-11-LABX-0063</idno>
					<orgName type="project" subtype="full">LABEX PRIMES</orgName>
				</org>
				<org type="funding" xml:id="_pyKZjYW">
					<idno type="grant-number">LS-2292</idno>
				</org>
			</listOrg>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Synchrotron Radiation X-Ray Phase Micro-computed Tomography as a New Method to Detect Iron Oxide Nanoparticles in the Brain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Marinescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Langer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Durand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Olivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chabrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rositi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chauveau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nighoghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Berthezène</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Peyrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wiart</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11307-013-0639-6</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Imaging and Biology</title>
		<title level="j" type="abbrev">Mol Imaging Biol</title>
		<idno type="ISSN">1536-1632</idno>
		<idno type="ISSNe">1860-2002</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="552" to="559" />
			<date type="published" when="2013-04-30">2013</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Marinescu M, Langer M, Durand A, Olivier C, Chabrol A, Rositi H, . . . Wiart M. Synchrotron Radiation X-Ray Phase Micro-computed Tomography as a New Method to Detect Iron Oxide Nanoparticles in the Brain. Mol Imaging Biol 2013;15(5):552-559.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Information-based analysis of X-ray in-line phase tomography with application to the detection of iron oxide nanoparticles in the brain</title>
		<author>
			<persName><forename type="first">Hugo</forename><surname>Rositi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Carole</forename><surname>Frindel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Max</forename><surname>Langer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marlène</forename><surname>Wiart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cécile</forename><surname>Olivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Françoise</forename><surname>Peyrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">David</forename><surname>Rousseau</surname></persName>
		</author>
		<idno type="DOI">10.1364/oe.21.027185</idno>
	</analytic>
	<monogr>
		<title level="j">Optics Express</title>
		<title level="j" type="abbrev">Opt. Express</title>
		<idno type="ISSNe">1094-4087</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page">27185</biblScope>
			<date type="published" when="2013-11-01">2013</date>
			<publisher>Optica Publishing Group</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Rositi H, Frindel C, Langer M, Wiart M, Olivier C, Peyrin F, Rousseau D. Information-based analysis of X-ray in-line phase tomography with application to the detection of iron oxide nanoparticles in the brain. Optics express 2013;21(22):27185-27196.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Spectral CT: a technology primer for contrast agent development</title>
		<author>
			<persName><forename type="first">Carsten</forename><forename type="middle">O</forename><surname>Schirra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><surname>Brendel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Anastasio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ewald</forename><surname>Roessl</surname></persName>
		</author>
		<idno type="DOI">10.1002/cmmi.1573</idno>
	</analytic>
	<monogr>
		<title level="j">Contrast Media &amp; Molecular Imaging</title>
		<title level="j" type="abbrev">Contrast Media &amp; Molecular</title>
		<idno type="ISSN">1555-4309</idno>
		<idno type="ISSNe">1555-4317</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="62" to="70" />
			<date type="published" when="2014-01">2014</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Schirra CO, Brendel B, Anastasio MA, Roessl E. Spectral CT: a technology primer for contrast agent development. Contrast media &amp; molecular imaging 2014;9(1):62-70.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Le Bas JF. In vivo K-edge imaging with synchrotron radiation</title>
		<author>
			<persName><forename type="first">H</forename><surname>Elleaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Charvet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Duc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Esteve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bertrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Corde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">.</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cellular and molecular biology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1065" to="1075" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Elleaume H, Charvet AM, Le Duc G, Esteve F, Bertrand B, Corde S, . . . Le Bas JF. In vivo K-edge imaging with synchrotron radiation. Cellular and molecular biology 2000;46(6):1065-1075.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
